Asha Das - Net Worth and Insider Trading

Asha Das Net Worth

The estimated net worth of Asha Das is at least $3,156 dollars as of 2024-11-05. Asha Das is the SVP & Chief Medical Officer of Tocagen Inc and owns about 167 shares of Tocagen Inc (TOCA) stock worth over $3,156. Details can be seen in Asha Das's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Asha Das has not made any transactions after 2017-04-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Asha Das

To

Asha Das Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Asha Das owns 2 companies in total, including Progenics Pharmaceuticals Inc (PGNX) , and Forte Biosciences Inc (FBRX) .

Click here to see the complete history of Asha Das’s form 4 insider trades.

Insider Ownership Summary of Asha Das

Ticker Comapny Transaction Date Type of Owner
PGNX Progenics Pharmaceuticals Inc 2020-06-19 Chief Medical Officer
FBRX Forte Biosciences Inc 2017-04-12 SVP & Chief Medical Officer

Asha Das Latest Holdings Summary

Asha Das currently owns a total of 1 stock. Asha Das owns 167 shares of Tocagen Inc (TOCA) as of April 19, 2017, with a value of $3,156.

Latest Holdings of Asha Das

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TOCA Tocagen Inc 2017-04-19 167 18.90 3,156

Holding Weightings of Asha Das


Asha Das Form 4 Trading Tracker

According to the SEC Form 4 filings, Asha Das has made a total of 0 transactions in Tocagen Inc (TOCA) over the past 5 years. The most-recent trade in Tocagen Inc is the acquisition of 167 shares on April 19, 2017, which cost Asha Das around $25,000.

Insider Trading History of Asha Das

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Asha Das Trading Performance

GuruFocus tracks the stock performance after each of Asha Das's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Asha Das is -26.61%. GuruFocus also compares Asha Das's trading performance to market benchmark return within the same time period. The performance of stocks bought by Asha Das within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Asha Das's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Asha Das

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.23 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10.37 LIMIT LIMIT LIMIT LIMIT LIMIT

Asha Das Ownership Network

Ownership Network List of Asha Das

No Data

Ownership Network Relation of Asha Das

Insider Network Chart

Asha Das Owned Company Details

What does Progenics Pharmaceuticals Inc do?

Who are the key executives at Progenics Pharmaceuticals Inc?

Asha Das is the Chief Medical Officer of Progenics Pharmaceuticals Inc. Other key executives at Progenics Pharmaceuticals Inc include 10 percent owner & other: See Explanation of Responses Balaji Venkataraman , 10 percent owner & other: See Explanation of Responses Virinder Nohria , and 10 percent owner Broadfin Healthcare Master Fund Ltd .

Progenics Pharmaceuticals Inc (PGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Progenics Pharmaceuticals Inc (PGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Progenics Pharmaceuticals Inc (PGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Progenics Pharmaceuticals Inc (PGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Progenics Pharmaceuticals Inc Insider Transactions

No Available Data

Asha Das Mailing Address

Above is the net worth, insider trading, and ownership report for Asha Das. You might contact Asha Das via mailing address: C/o Progenics Pharmaceuticals, Inc., 1 World Trade Center, 47th Fl, Suite J, New York Ny 10007.